Axena Health, Inc., a women's health company redefining the standard of care for pelvic health conditions through clinically proven, non-invasive treatments, today announced a new publication entitled ...
Tom Nolan reviews this week’s research Post-thrombotic syndrome affects up to half of people within two years of a lower leg ...
Tovecimig (a DLL4 x VEGF-A bispecific antibody) in combination with paclitaxel demonstrated a highly statistically significant improvement versus paclitaxel alone in the key secondary endpoint of ...
Johnson & Johnson has initiated the PERSIGMA randomized controlled trial (RCT), one of the first randomized studies ...
Company to leverage strong durability and survival data in second-line and later metastatic squamous cell anal carcinomaPivotal study expected to ...
A randomized field experiment found Google AI Overviews reduced organic clicks on triggered queries by 38%, while user ...
In adults with type 2 diabetes inadequately controlled on metformin alone, the combination of glimepiride, voglibose, and ...
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that its pivotal Phase 3 clinical trial evaluating rexlemestrocel-L ...
A Nature Medicine study found that healthy Australian adults were widely exposed to plastic-associated chemicals, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results